Media Relations

Press Release:


FAU’s Clinical Research Group in Need of Volunteers for Alzheimer’s Disease Study

            BOCA RATON, FL (July 10, 2008) – Florida Atlantic University’s Charles E. Schmidt College of Biomedical Science’s Clinical Research Group is currently conducting a study to determine if Namenda, an FDA-approved medication, can help preserve the driving abilities of patients with mild Alzheimer’s Disease.

            The study, led by Dr. Peter Holland, will be conducted over a one to two year period, and will consist of comprehensive neurological evaluations, road driving tests, neuropsychological testing, vision testing and close safety monitoring.  

            The department is looking for participants to take part in the study. Volunteers must be at least 60 years or older and have a valid driver’s license in order to be considered.   There is no cost for any procedures or study medication, and those chosen will be reimbursed $35 per visit for transportation expenses.

            For more information, contact Lori Fisher at 561-297-0164 or


Privacy Policy | University Regulations and Policies | Emergency Information | Get Help | Contact Us

An Equal Opportunity/Equal Access Institution
© Copyright 2016. Florida Atlantic University.
Florida Atlantic University
 Last Modified 9/7/16